PILON, CATIA
 Distribuzione geografica
Continente #
NA - Nord America 1.246
EU - Europa 137
AS - Asia 74
OC - Oceania 2
Totale 1.459
Nazione #
US - Stati Uniti d'America 1.245
CN - Cina 65
IT - Italia 40
DE - Germania 25
FI - Finlandia 24
UA - Ucraina 18
SE - Svezia 14
GB - Regno Unito 12
VN - Vietnam 5
FR - Francia 3
AU - Australia 2
IN - India 2
BE - Belgio 1
CA - Canada 1
ID - Indonesia 1
JP - Giappone 1
Totale 1.459
Città #
Fairfield 212
Woodbridge 140
Houston 130
Ann Arbor 104
Jacksonville 86
Chandler 83
Cambridge 74
Seattle 66
Wilmington 66
Ashburn 58
Princeton 28
Padova 27
San Diego 21
Beijing 15
Nanjing 14
Roxbury 13
Des Moines 11
Medford 9
Helsinki 8
Nanchang 6
Dong Ket 5
Shenyang 5
London 4
Norwalk 4
Boardman 3
Hanover 3
Hebei 3
Jiaxing 3
Jinan 3
Milan 3
Changsha 2
Guangzhou 2
Hefei 2
Kharkiv 2
Paris 2
Phoenix 2
Redwood City 2
Veroli 2
Baotou 1
Borås 1
Cavarzere 1
Fuzhou 1
Gallipolis 1
Kunming 1
Lanzhou 1
Las Vegas 1
Munich 1
Nanning 1
Ogden 1
Orange 1
Pune 1
Rende 1
Semarang 1
Southwark 1
Squamish 1
Tappahannock 1
Wandsworth 1
Wuhan 1
Totale 1.243
Nome #
The role of 21-hydroxylase in the pathogenesis of adrenal masses: Review of the literature and focus on our own experience 120
Effects of Taxol on the human NCI-H295 adrenocortical carcinoma cell line. 118
Insulin signaling in adipose tissue of patients with primary aldosteronism 116
Analysis of Insulin Sensitivity in Adipose Tissue of Patients with Primary Aldosteronism 102
Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism 90
Isolated R171Q amino acid change in MEN1 gene: polymorphism or mutation? 87
null 82
Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series 82
Retention of heterozygosity at chromosome 7p22 and 11q13 in aldosterone-producing tumors of patients with familial hyperaldosteronism not remediable by glucocorticoids 75
Retention of heterozygosity at chromosome 7p22 and 11q13 in aldosterone-producing tumours of patients with familial hyperaldosteronism not remediable by glucocorticoids 75
Primary aldosteronism and metabolic syndrome. 74
Genetic studies in familial aldosteronism not suppressible by dexamethasone 68
CYP11B2 gene polymorphisms in idiopathic hyperaldosteronism. 68
Statins reduce intratumor cholesterol affecting adrenocortical cancer growth 64
Role of Scaffold Protein Proline-, Glutamic Acid-, and Leucine-Rich Protein 1 (PELP1) in the Modulation of Adrenocortical Cancer Cell Growth 61
1?,25-Dihydroxyvitamin D3 inhibits the human H295R cell proliferation by cell cycle arrest: A model for a protective role of vitamin D receptor against adrenocortical cancer. 54
Targeting Estrogen Receptor-  Reduces Adrenocortical Cancer (ACC) Cell Growth in Vitro and in Vivo: Potential Therapeutic Role of Selective Estrogen Receptor Modulators (SERMs) for ACC Treatment 53
DNA methylation of steroidogenic enzymes in benign adrenocortical tumors: New insights in aldosterone-producing adenomas 42
Diagnosi molecolare della neoplasia endocrina multipla tipo 2 34
Methylation status of Vitamin D receptor gene promoter in benign and malignant adrenal tumors 11
Totale 1.476
Categoria #
all - tutte 4.834
article - articoli 4.727
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.561


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201975 0 0 0 0 0 0 0 0 0 0 40 35
2019/2020336 46 8 5 46 31 25 25 50 34 29 21 16
2020/2021225 9 17 3 17 11 24 12 23 41 18 23 27
2021/2022258 5 38 31 7 16 20 15 25 10 11 34 46
2022/2023197 37 7 3 17 36 24 0 14 37 2 10 10
2023/202454 6 21 11 8 3 1 0 3 1 0 0 0
Totale 1.476